Arcus Biosciences, Inc. (RCUS) Social Stream



Arcus Biosciences, Inc. (RCUS): $27.46

-0.54 (-1.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RCUS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Featured Post From StockTwits About RCUS

$RCUS New SEC Filing: 8-K Emp Changes - Arcus Biosciences, Inc. (0001724521) August 10


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 10, 2021, in connection with his departure from Gilead Sciences, Inc., Michael Quigley, Ph.D., resigned as a member of Arcus Biosciences, Inc.'s Board of Directors, effective upon the appointment of Gilead's new director designee pursuant to the Investor Rights Agreement dated May 27, 2020 by and between Arcus and Gilead. On August 10, 2021, the Board appointed Linda Higgins, Senior Vice President of Research, External Innovation at Gilead, as a Class III director to fill the vacancy left by Dr. Quigley's resignation. Dr. Higgi (...)

https://mkn.re/95114
MarketNewswire, published August 11, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4356 seconds.